ArticleFrontiers in medicine2026
New perspective of diagnosis and treatment of hypertension: fusion analysis of TCM syndrome and SPECT kidney dynamic imaging technology.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertension is a major global public health burden, with unsatisfactory blood pressure control rates and insufficient attention to early renal hemodynamic impairment. Traditional Chinese Medicine (TCM) syndrome differentiation provides holistic and individualized insights into disease pathogenesis, while single-photon emission computed tomography (SPECT) renal dynamic imaging enables sensitive, quantitative assessment of early renal perfusion and glomerular filtration rate (GFR) abnormalities. This study explicitly positions the TCM-SPECT fusion model as an early functional screening tool for hypertensive renal damage, complementary to-but not a replacement for-standard structural imaging (CT/MRI) and routine nephrological workup. We aimed to explore the correlation between TCM syndromes and SPECT renal parameters and propose an integrated screening framework for hypertension. A retrospective observational study was conducted on 33 primary hypertensive patients who underwent standardized TCM syndrome differentiation and 99mTc-DTPA SPECT renal dynamic imaging. Renal perfusion peak time, split and total GFR were analyzed across syndromes. Twenty-five patients had complete GFR data; 8 patients were excluded due to motion artifact or suboptimal radiotracer uptake, with sensitivity analysis confirming no systematic bias. Different TCM syndromes exhibited distinct renal functional profiles: Kidney Yang Deficiency (KYD) showed the most severe impairment, with total GFR of 81.6 ± 12.5 mL/min/1.73 m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.